Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Calculi | 7 | 2015 | 340 | 1.350 |
Why?
|
| Calcium Phosphates | 3 | 2015 | 77 | 0.710 |
Why?
|
| Calcium Oxalate | 4 | 2015 | 185 | 0.710 |
Why?
|
| Hypercalciuria | 3 | 2015 | 47 | 0.680 |
Why?
|
| Dissection | 5 | 2012 | 43 | 0.570 |
Why?
|
| Esophagoscopy | 3 | 2012 | 89 | 0.500 |
Why?
|
| Esophageal Neoplasms | 3 | 2012 | 329 | 0.480 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2012 | 237 | 0.480 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2015 | 60 | 0.470 |
Why?
|
| Kidney Tubules | 2 | 2015 | 93 | 0.460 |
Why?
|
| Surgical Instruments | 2 | 2011 | 58 | 0.430 |
Why?
|
| Calcium | 4 | 2015 | 1170 | 0.420 |
Why?
|
| Insufflation | 1 | 2012 | 10 | 0.420 |
Why?
|
| Air | 1 | 2012 | 62 | 0.410 |
Why?
|
| Stomach Diseases | 1 | 2011 | 19 | 0.410 |
Why?
|
| Hamartoma | 1 | 2011 | 34 | 0.400 |
Why?
|
| Hemostasis, Endoscopic | 4 | 2012 | 16 | 0.390 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 202 | 0.390 |
Why?
|
| Endoscopy, Digestive System | 1 | 2009 | 67 | 0.340 |
Why?
|
| Colonoscopy | 4 | 2012 | 273 | 0.340 |
Why?
|
| Diverticulum, Colon | 3 | 2012 | 10 | 0.300 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 190 | 0.300 |
Why?
|
| X-Ray Microtomography | 2 | 2014 | 81 | 0.290 |
Why?
|
| Parathyroid Hormone | 2 | 2015 | 216 | 0.270 |
Why?
|
| Nephrocalcinosis | 1 | 2015 | 9 | 0.260 |
Why?
|
| Renal Reabsorption | 1 | 2015 | 7 | 0.260 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2015 | 32 | 0.260 |
Why?
|
| Kidney Tubules, Distal | 1 | 2015 | 20 | 0.260 |
Why?
|
| Medullary Sponge Kidney | 1 | 2015 | 6 | 0.260 |
Why?
|
| Renal Elimination | 1 | 2015 | 8 | 0.250 |
Why?
|
| Lithotripsy | 1 | 2015 | 42 | 0.250 |
Why?
|
| Nephrolithiasis | 1 | 2015 | 23 | 0.250 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2015 | 68 | 0.240 |
Why?
|
| Kidney Medulla | 1 | 2014 | 80 | 0.240 |
Why?
|
| Durapatite | 1 | 2014 | 28 | 0.240 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2013 | 4 | 0.230 |
Why?
|
| Vitamin D Deficiency | 1 | 2015 | 103 | 0.230 |
Why?
|
| Oxalates | 1 | 2013 | 48 | 0.230 |
Why?
|
| Thiazides | 1 | 2013 | 16 | 0.230 |
Why?
|
| Chlorthalidone | 1 | 2013 | 18 | 0.230 |
Why?
|
| Middle Aged | 21 | 2015 | 25612 | 0.230 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 75 | 0.220 |
Why?
|
| Osteogenesis | 1 | 2015 | 246 | 0.220 |
Why?
|
| Diuretics | 1 | 2013 | 75 | 0.220 |
Why?
|
| Vitamin D | 1 | 2015 | 267 | 0.210 |
Why?
|
| Aged | 17 | 2015 | 18878 | 0.210 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 223 | 0.200 |
Why?
|
| Gastroscopy | 2 | 2011 | 24 | 0.190 |
Why?
|
| Adult | 13 | 2015 | 26266 | 0.190 |
Why?
|
| Female | 21 | 2015 | 45621 | 0.190 |
Why?
|
| Male | 22 | 2015 | 41896 | 0.190 |
Why?
|
| Carcinoid Tumor | 2 | 2011 | 43 | 0.190 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2011 | 156 | 0.170 |
Why?
|
| Humans | 28 | 2015 | 88365 | 0.170 |
Why?
|
| Esophagectomy | 2 | 2010 | 91 | 0.160 |
Why?
|
| Stomach Neoplasms | 2 | 2011 | 269 | 0.150 |
Why?
|
| Time Factors | 5 | 2015 | 5302 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2013 | 1349 | 0.130 |
Why?
|
| Aged, 80 and over | 6 | 2012 | 6704 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2633 | 0.120 |
Why?
|
| Japan | 2 | 2012 | 303 | 0.120 |
Why?
|
| Postprandial Period | 2 | 2015 | 47 | 0.120 |
Why?
|
| Gastric Mucosa | 2 | 2011 | 66 | 0.120 |
Why?
|
| Fasting | 2 | 2015 | 163 | 0.120 |
Why?
|
| Epirubicin | 1 | 2013 | 14 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2013 | 8852 | 0.110 |
Why?
|
| Colon, Ascending | 1 | 2012 | 1 | 0.110 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 60 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 116 | 0.110 |
Why?
|
| Meperidine | 1 | 2012 | 13 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2010 | 1093 | 0.100 |
Why?
|
| Midazolam | 1 | 2012 | 48 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 2012 | 61 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2013 | 8136 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2012 | 66 | 0.100 |
Why?
|
| Jejunal Diseases | 1 | 2011 | 10 | 0.100 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2011 | 11 | 0.100 |
Why?
|
| Diverticulosis, Colonic | 1 | 2011 | 2 | 0.100 |
Why?
|
| Ligation | 4 | 2011 | 51 | 0.100 |
Why?
|
| Diverticulum | 1 | 2011 | 45 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 130 | 0.090 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 803 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 46 | 0.090 |
Why?
|
| Colonoscopes | 1 | 2010 | 13 | 0.090 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 110 | 0.090 |
Why?
|
| Biopsy | 2 | 2015 | 1187 | 0.090 |
Why?
|
| Cecal Neoplasms | 1 | 2010 | 5 | 0.090 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2010 | 8 | 0.090 |
Why?
|
| Ileal Neoplasms | 1 | 2010 | 9 | 0.090 |
Why?
|
| Clarithromycin | 1 | 2009 | 7 | 0.090 |
Why?
|
| Risk Factors | 4 | 2015 | 5435 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2009 | 36 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2009 | 36 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2010 | 102 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2009 | 75 | 0.080 |
Why?
|
| Endosonography | 1 | 2009 | 98 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 218 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 404 | 0.080 |
Why?
|
| Length of Stay | 1 | 2012 | 726 | 0.080 |
Why?
|
| Rectal Neoplasms | 1 | 2009 | 127 | 0.080 |
Why?
|
| Models, Biological | 2 | 2015 | 1764 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 435 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2011 | 2276 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2009 | 399 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2013 | 3655 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 769 | 0.070 |
Why?
|
| Ammonium Chloride | 1 | 2015 | 22 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2015 | 48 | 0.060 |
Why?
|
| Bicarbonates | 1 | 2015 | 60 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 66 | 0.060 |
Why?
|
| Sus scrofa | 1 | 2015 | 50 | 0.060 |
Why?
|
| Phosphorus | 1 | 2015 | 116 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 73 | 0.060 |
Why?
|
| Magnesium | 1 | 2015 | 177 | 0.060 |
Why?
|
| Urodynamics | 1 | 2015 | 122 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 1688 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2015 | 128 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 773 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 1184 | 0.060 |
Why?
|
| Sodium | 1 | 2015 | 331 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 135 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 498 | 0.060 |
Why?
|
| Linear Models | 1 | 2015 | 423 | 0.060 |
Why?
|
| Hyperoxaluria | 1 | 2013 | 26 | 0.060 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 279 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 165 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 102 | 0.050 |
Why?
|
| Calcinosis | 1 | 2014 | 230 | 0.050 |
Why?
|
| Young Adult | 2 | 2015 | 6179 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 966 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 1061 | 0.050 |
Why?
|
| Kidney Diseases | 1 | 2014 | 318 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2015 | 891 | 0.050 |
Why?
|
| Adolescent | 2 | 2014 | 9138 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1847 | 0.050 |
Why?
|
| Esophagoscopes | 2 | 2010 | 3 | 0.040 |
Why?
|
| Esophageal Stenosis | 2 | 2010 | 26 | 0.040 |
Why?
|
| Biomarkers | 1 | 2015 | 1754 | 0.040 |
Why?
|
| Catheterization | 2 | 2010 | 238 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 1153 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 1034 | 0.040 |
Why?
|
| Prognosis | 1 | 2015 | 3746 | 0.040 |
Why?
|
| Infant | 1 | 2013 | 3115 | 0.040 |
Why?
|
| Algorithms | 1 | 2015 | 1857 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2013 | 3673 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1587 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2013 | 2833 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1857 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2013 | 36 | 0.030 |
Why?
|
| United States | 1 | 2015 | 6867 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 289 | 0.030 |
Why?
|
| Epinephrine | 1 | 2011 | 86 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 55 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 255 | 0.020 |
Why?
|
| Amoxicillin | 1 | 2009 | 13 | 0.020 |
Why?
|
| Minocycline | 1 | 2009 | 15 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 166 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 307 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 861 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1881 | 0.020 |
Why?
|
| Equipment Design | 1 | 2010 | 415 | 0.020 |
Why?
|
| Water | 1 | 2010 | 284 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 168 | 0.020 |
Why?
|
| Reoperation | 1 | 2011 | 606 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 1170 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2010 | 423 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 27134 | 0.020 |
Why?
|